←Back to feed
🧠 AI🟢 BullishImportance 7/10
AD-CARE: A Guideline-grounded, Modality-agnostic LLM Agent for Real-world Alzheimer's Disease Diagnosis with Multi-cohort Assessment, Fairness Analysis, and Reader Study
arXiv – CS AI|Wenlong Hou, Sheng Bi, Guangqian Yang, Lihao Liu, Ye Du, Hanxiao Xue, Juncheng Wang, Yuxiang Feng, Yue Xun, Nanxi Yu, Ning Mao, Mo Yang, Yi Wah Eva Cheung, Ling Long, Kay Chen Tan, Lequan Yu, Xiaomeng Ma, Shaozhen Yan, Shujun Wang|
🤖AI Summary
Researchers developed AD-CARE, an AI agent that uses large language models to diagnose Alzheimer's disease from incomplete medical data across multiple modalities. The system achieved 84.9% diagnostic accuracy across 10,303 cases and improved physician decision-making speed and accuracy in clinical studies.
Key Takeaways
- →AD-CARE demonstrated 84.9% diagnostic accuracy across six cohorts comprising 10,303 Alzheimer's disease cases.
- →The AI agent improved neurologist and radiologist accuracy by 6-11% while reducing decision time by more than half.
- →The system reduced performance disparities across racial and age groups by 21-68% and 28-51% respectively.
- →AD-CARE works with incomplete, heterogeneous medical data without requiring imputation of missing modalities.
- →The framework showed consistent performance improvements over eight different backbone LLMs with robust cross-dataset accuracy of 80.4-98.8%.
#ai-healthcare#medical-ai#alzheimers#clinical-ai#llm#medical-diagnosis#healthcare-automation#ai-agents#medical-research
Read Original →via arXiv – CS AI
Act on this with AI
Stay ahead of the market.
Connect your wallet to an AI agent. It reads balances, proposes swaps and bridges across 15 chains — you keep full control of your keys.
Related Articles